Cite Filings / LCTX / 0001493152-24-005039
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
424B5

Prospectus

Lineage Cell Therapeutics, Inc. · Filed 2024-02-06 · Acc 0001493152-24-005039

Documents 1

  • 424B5 Prospectus , form424b5.htm

Around this filing

  • 2024-02-08 4 Director bought 96,155 shares at $1.04 ($100,001)
  • 2024-02-08 4 Director bought 6,730,770 shares at $1.04 ($7,000,001)
  • 2024-02-08 SC 13D/A Beneficial Ownership Report
  • 2024-02-06 424B5 Prospectus
  • 2024-02-06 8-K Material agreement · Other events
  • 2024-02-06 424B5 Prospectus
  • 2023-05-18 424B5 Prospectus

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading form424b5.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…